the o2h kickstarter competition 5.0 exclusively for American biotech start-ups
give your startup a boost of chemistry..
Last date to apply - 10th Oct 2023 Know moreabout o2h discovery
o2h discovery is a Contract Research Organisation which has an integrated drug discovery platform operating from its state-of-the-art research centre in Ahmedabad, India and The Mill SciTech Park, Cambridge, UK. We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development.
o2h ChaiTime Webinars
A series of lively ChaiTime webinars where we discuss various interesting subjects from ‘Early Stage Investing in Post Covid-19 Environment’ to ‘Building a Billion Dollar Biotech’
Chemistry in the Cloud TM
o2h group launched revolutionary project management app for drug discovery. The app’s full suite of project management tools is available exclusively to live project collaborators and a lighter version is open for researchers looking for a quote for the synthesis of small molecules
CambridgesquaredTM
We believe in collaboration in drug discovery and o2h group are building a global community of medicinal chemists and biologists between Cambridge, UK, and Cambridge, MA, through a series of events
news
the o2h collaborative innovation conference
o2h group announced to the world India’s first-of-a-kind conference for collaborative innovation in Science, Technology and Social Enterprise to be held in Ahmedabad, India. o2h group is collaborating with others in Ahmedabad to build a community of fearless innovators from a wide range of fields. The core theme of the conference is that innovations work best when people collaborate, share and work together across boundaries in their local clusters. o2h group is inviting passionate scientists, techies, entrepreneurs, social entrepreneurs, community-workers, artists, engineers, academics, investors, journalists, lawyers, accountants, architects and big businesses with a collective passion to design and shape new discoveries that impact society